As of 2026-10-09, the Relative Valuation of Kala Pharmaceuticals Inc (KALA) is (9.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 USD, the upside of Kala Pharmaceuticals Inc based on Relative Valuation is -3411.4%.
The range of the Relative Valuation is (8.34) - (10.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 27.0x | 17.5x |
| Forward P/E multiples | 15.3x - 20.1x | 18.6x |
| Fair Price | (8.34) - (10.95) | (9.82) |
| Upside | -2910.5% - -3791.1% | -3411.4% |
| Date | P/E |
| 2026-10-07 | -0.66 |
| 2026-10-06 | -0.67 |
| 2026-10-05 | -0.67 |
| 2026-10-02 | -0.71 |
| 2026-10-01 | -0.77 |
| 2026-09-30 | -0.79 |
| 2026-09-29 | -0.92 |
| 2026-09-28 | -0.83 |
| 2026-09-25 | -0.87 |
| 2026-09-24 | -1.03 |
| 2026-09-23 | -1.03 |
| 2026-09-22 | -1.10 |
| 2026-09-21 | -1.03 |
| 2026-09-18 | -0.99 |
| 2026-09-17 | -1.04 |
| 2026-09-16 | -0.96 |
| 2026-09-15 | -0.93 |
| 2026-09-14 | -0.99 |
| 2026-09-11 | -1.05 |
| 2026-09-10 | -1.03 |
| 2026-09-09 | -1.02 |
| 2026-09-08 | -0.99 |
| 2026-09-04 | -0.93 |
| 2026-09-03 | -1.03 |
| 2026-09-02 | -0.96 |
| 2026-09-01 | -0.98 |
| 2026-08-31 | -1.24 |
| 2026-08-28 | -1.27 |
| 2026-08-27 | -1.49 |
| 2026-08-26 | -1.50 |
| 2026-08-25 | -1.51 |
| 2026-08-24 | -1.46 |
| 2026-08-21 | -1.51 |
| 2026-08-20 | -1.54 |
| 2026-08-19 | -1.65 |
| 2026-08-18 | -1.65 |
| 2026-08-17 | -1.67 |
| 2026-08-14 | -1.74 |
| 2026-08-13 | -1.70 |
| 2026-08-12 | -1.62 |
| 2026-08-11 | -1.55 |
| 2026-08-10 | -1.39 |
| 2026-08-07 | -1.37 |
| 2026-08-06 | -1.35 |
| 2026-08-05 | -1.29 |
| 2026-08-04 | -1.37 |
| 2026-08-03 | -1.44 |
| 2026-07-31 | -1.39 |
| 2026-07-30 | -1.34 |
| 2026-07-29 | -1.24 |